Navigation Links
ACORN's Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting
Date:3/2/2009

MEMPHIS, Tenn., March 2 /PRNewswire-USNewswire/ -- Accelerated Community Oncology Research Network (ACORN(TM)), an oncology focused research network, announced today the highlights of its annual Principal Investigators' Meeting held in Scottsdale, AZ in February. Medical oncologists from community-based oncology practices throughout the United States met to discuss the latest cancer research advances, emerging treatment trends, as well as promising new molecules in the drug pipeline.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )

2008 represented a banner year for ACORN and its network members. 74 different sponsors, representing 93 industry-sponsored trials, engaged the ACORN Network. Additionally, 21 ACORN investigator initiated trials were open in 2008. The ACORN portfolio included studies of 41 different investigational agents in 2008. 62% of ACORN's 2008 studies were Phase II with the majority of the trials focusing on cancers of the lung, breast, ovary, colon/rectum, or pancreas. ACORN also delivered research opportunities for less frequently seen cancers to its member practices to make treatments of all cancer types available.

"Commitment to research excellence is integral to the ACORN process as is thorough education of all staff members. We continue to identify new processes to facilitate rapid deployment of clinical trials to community-based oncology practices while experiencing banner growth," remarked Edward J. Stepanski, PhD, COO, ACORN.

Practicing oncologists in the ACORN Network serve as Tumor Committee Chairs. Those presenting at the 2009 Meeting included Mark Keaton, MD, Augusta Oncology Associates, Augusta, GA, Gastroenterology; Lee Schwartzberg, MD, FACP, The West Clinic, Memphis, TN, Breast Cancer; Frederick Schnell, MD, FACP, Central Georgia Cancer Care, Macon, GA, Lymphoma; Brian Samuels, MD, FACP, FCP(SA), Kootenai Cancer Center, Coeur d'Alene, ID, Melanoma, Sarcoma, and Rare Cancer Trials; Johnetta Blakely, MD, The West Clinic, Memphis, TN, Phase 1 Trials; David Henry, MD, Pennsylvania Oncology Hematology Associates, Philadelphia, PA, Supportive Care Trials; and Brad Somer, MD, The West Clinic, Memphis, TN, Genitourinary Trials.

The ACORN Network seeks to make clinical research an integral part of community-based cancer care by giving every patient an equal opportunity to participate in clinical research. By making research a vital part of clinical operations and using technology to streamline the process, ACORN enhances the speed, accuracy, and productivity of clinical trial operations. More rapid development time for new agents results in providing more effective care to benefit patients faster than previously possible. ACORN provides Contracting, Budgeting, Regulatory Affairs, Project Management, Data Management, Quality Assurance, Statistical Analysis, Medical Writing, and Site Development to its participating members and pharmaceutical sponsors.

"In 2009, ACORN will accelerate its commitment to oncology research by expanding opportunities for both members and sponsors," announced Lee S. Schwartzberg, MD, FACP, President of ACORN.

For additional information, contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878 or visit www.ACORNresearch.net.

Accelerated Community Oncology Research Network, Inc.(TM) (ACORN)

ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Contract Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

    Contact Information:
    Liz Conway
    (901) 435-5570
    lconway@sosacorn.com
    www.ACORNresearch.net

    Deborah D. Coble
    901-683-0055 x1312
    dcoble@sosacorn.com


'/>"/>
SOURCE Accelerated Community Oncology Research Network, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kenyan malaria success strengthens call for free insecticide-treated nets for all
2. Eligard(R) six-month formulation successfully completes European approval procedure
3. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
4. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
5. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
6. Bacteria successful in cancer treatment
7. Congress Poised to Add Millions of Uninsured Children to Successful, Bipartisan Health Plan
8. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
9. Success of Shape Up Somerville childhood obesity intervention to be presented
10. Cell growth technology promises more successful drug development
11. CIGNA Group Insurance Celebrates Return to Work Success During National Rehabilitation Awareness Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology: